GlassScriptPhysician profile
Frank Ryan Harris
NPI 1891144572
$2,495.91
in general payments reported to CMS, 2019-2025
34 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.48 · 2020: $296 · 2021: $836 · 2022: $943 · 2023: $223 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $263.93 | 2021-2023 | Arexvy |
| Novo Nordisk INC | $255.82 | 2019-2022 | |
| Abbvie INC. | $198.13 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $188.80 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.30 | 2021-2022 | |
| Pfizer INC. | $148.34 | 2020-2022 | |
| Amgen INC. | $148.12 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.60 | 2019-2022 | |
| Astellas Pharma US INC | $107.90 | 2023 | Veozah |
| Lilly USA, LLC | $98.14 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.06 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.01 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $57.98 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $52.90 | 2021-2022 | |
| Amarin Pharma, INC. | $50.93 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $42.21 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.43 | 2021-2022 | |
| Insulet Corporation | $36.65 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $35.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.24 | 2021 | |
| Sanofi Pasteur INC. | $33.23 | 2021-2022 | |
| Eisai INC. | $31.75 | 2020-2021 | |
| Zoll Respicardia, INC. | $26.91 | 2022 | |
| Neurocrine Biosciences, INC. | $22.42 | 2022 | |
| Zealand Pharma US, INC. | $20.73 | 2022 | |
| Harmony Biosciences LLC | $19.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.57 | 2022 | |
| Daiichi Sankyo INC. | $15.86 | 2021 | |
| Alfasigma USA, INC. | $15.38 | 2021 | |
| Dexcom, INC. | $14.76 | 2021 | |
| Medicure Pharma INC. | $13.34 | 2021 | |
| Vistapharm, INC. | $12.79 | 2021 | |
| Radius Health, INC. | $12.27 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.